Darlene Horton, M.D. Made Chief Medical Officer at Nile Therapeutics.

Nile Therapeutics, Inc. (OTCQB: NLTX), a biopharmaceutical company, appointed Darlene Horton, M.D. as its Chief Medical Officer. Darlene had been Chief Medical Officer of Itero Biopharmaceuticals, and before that, was Senior Vice President, Clinical Research at Scios, Inc., a Johnson & Johnson (J&J) company. See prnewswire press release.